Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2011 (Vol. 31, No. 13)

IMAIOS

URL:www.imaios.com/en
  • Detailed modules, most of which are free
  • Some resources on site are restricted (require payment)

It is true that a career in a medical field, be it clinical or basic research, requires a lifetime of learning. It is also true that most people have this pesky habit of forgetting things. Fortunately, there are resources out there that address both of these considerations, one of which is IMAIOS. This website provides a number of educational modules for those in a healthcare-related field, including a large number of anatomy tutorials, clinical cases, and an extensive course on MRI. The good news is that most of these detailed educational resources are completely free of charge. The bad news is that I just wrote “most,” which means that there is a small pool of “premium” resources that are not free. (Apparently, cranial nerve diagrams are a precious commodity.) So whether you’re one of those “life-long learners” or you’ve simply forgotten your thorax anatomy, IMAIOS is a great website.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »